Podchaser Logo
Home
FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

Released Monday, 9th January 2023
Good episode? Give it some love!
FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

Monday, 9th January 2023
Good episode? Give it some love!
Rate Episode

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a masitinib trial that is expected to include up to 800 participants at about 75 sites in Europe, North America, Israel, and Africa.
He also reads “This New Year, I Resolve to Let Myself Hope” by Benjamin Hofmeister, from his column “Chairborne.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features